Aditxt (ADTX) announced that its subsidiary, Pearsanta, has begun enrollment in their prospective clinical study evaluating the Mitomic Endometriosis Test, a novel blood-based diagnostic designed to aid in the early detection of endometriosis.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX: